Texas Permanent School Fund Corp Grows Stock Position in Perrigo Company plc (NYSE:PRGO)

Texas Permanent School Fund Corp increased its holdings in shares of Perrigo Company plc (NYSE:PRGOFree Report) by 1.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 119,298 shares of the company’s stock after buying an additional 1,357 shares during the quarter. Texas Permanent School Fund Corp owned about 0.09% of Perrigo worth $3,064,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Perrigo by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 14,994,309 shares of the company’s stock worth $482,517,000 after purchasing an additional 91,322 shares during the period. Cooke & Bieler LP raised its holdings in shares of Perrigo by 0.9% in the 2nd quarter. Cooke & Bieler LP now owns 3,501,401 shares of the company’s stock worth $89,916,000 after purchasing an additional 30,150 shares during the period. DAVENPORT & Co LLC raised its holdings in shares of Perrigo by 10.1% in the 1st quarter. DAVENPORT & Co LLC now owns 3,449,352 shares of the company’s stock worth $111,035,000 after purchasing an additional 317,552 shares during the period. Perpetual Ltd grew its stake in shares of Perrigo by 20.5% in the first quarter. Perpetual Ltd now owns 2,780,984 shares of the company’s stock valued at $87,490,000 after buying an additional 472,245 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Perrigo by 2.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,417,025 shares of the company’s stock valued at $45,600,000 after buying an additional 37,984 shares in the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

PRGO has been the subject of a number of recent research reports. StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a research note on Monday, August 5th. Piper Sandler lowered their target price on Perrigo from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, July 11th.

View Our Latest Stock Analysis on Perrigo

Insider Transactions at Perrigo

In other news, Director Katherine C. Doyle sold 8,954 shares of Perrigo stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the transaction, the director now owns 6,009 shares in the company, valued at approximately $164,045.70. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Katherine C. Doyle sold 8,954 shares of Perrigo stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the transaction, the director now owns 6,009 shares in the company, valued at approximately $164,045.70. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Svend Andersen sold 28,300 shares of Perrigo stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $27.75, for a total value of $785,325.00. Following the completion of the transaction, the executive vice president now owns 73,553 shares of the company’s stock, valued at approximately $2,041,095.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,254 shares of company stock worth $1,411,969. 0.70% of the stock is currently owned by corporate insiders.

Perrigo Price Performance

Shares of NYSE PRGO opened at $27.75 on Monday. Perrigo Company plc has a fifty-two week low of $24.82 and a fifty-two week high of $34.60. The business has a 50 day moving average price of $27.83 and a two-hundred day moving average price of $28.77. The company has a quick ratio of 1.24, a current ratio of 1.99 and a debt-to-equity ratio of 0.80. The firm has a market cap of $3.78 billion, a PE ratio of -396.43 and a beta of 0.49.

Perrigo (NYSE:PRGOGet Free Report) last issued its quarterly earnings data on Friday, August 2nd. The company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.07. Perrigo had a positive return on equity of 6.79% and a negative net margin of 2.81%. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter last year, the firm earned $0.63 EPS. Perrigo’s quarterly revenue was down 10.7% on a year-over-year basis. Sell-side analysts expect that Perrigo Company plc will post 2.57 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 17th. Shareholders of record on Friday, August 30th will be paid a dividend of $0.276 per share. The ex-dividend date is Friday, August 30th. This represents a $1.10 dividend on an annualized basis and a yield of 3.98%. Perrigo’s dividend payout ratio (DPR) is presently -1,571.43%.

Perrigo Company Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.